Analysis of COVID-19 patient outcomes with molnupiravir treatment and the role of risk factors: a single-centre retrospective descriptive study
Molnupiravir treatment was linked to reduced risks of hospitalization and death, particularly in high-risk patients. Vaccination provided additional protection, and obesity obstructive pulmonary disease and autoimmune diseases were significant risk factors for severe outcomes.
Authors
- Štefan Porubčin (ORCID: https://orcid.org/0000-0002-2020-7573)
- Kvetoslava Rimárová (ORCID: https://orcid.org/0000-0003-4364-0553)
- Alena Rovňáková (ORCID: https://orcid.org/0000-0002-2282-1366)
- Erik Dorko (ORCID: https://orcid.org/0000-0002-6520-1693)
- Ondřej Zahornacký (ORCID: https://orcid.org/0000-0002-2682-4994)
- Pavol Jarčuška (ORCID: https://orcid.org/0000-0001-8706-1751)
- Paulína Kubalcová
- Dária Semenovová
Institutions
- University of Pavol Jozef Šafárik (SK)
- Slovak Academy of Sciences (SK)
Publication Details
- Journal
- Central European Journal of Public Health
- Published
- 2024-12-31
- DOI
- https://doi.org/10.21101/cejph.a8398
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kultúrna a Edukacná Grantová Agentúra MŠVVaŠ SR